Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
Open Access
- 9 September 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 27, e931630-e931630-11
- https://doi.org/10.12659/msm.931630
Abstract
Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation - Article abstract #931630This publication has 35 references indexed in Scilit:
- Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA)British Journal of Cancer, 2015
- Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivoCancer Cell International, 2014
- Galangin induces human colon cancer cell death via the mitochondrial dysfunction and caspase-dependent pathwayExperimental Biology and Medicine, 2013
- Dietary Flavonoid Intake and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition CohortAmerican Journal of Epidemiology, 2013
- Immune effects of 5-fluorouracilOncoImmunology, 2013
- Cutting Edge: Proteolytic Inactivation of Poly(ADP-Ribose) Polymerase 1 by the Nlrp3 and Nlrc4 InflammasomesThe Journal of Immunology, 2010
- Galangin induces apoptosis of hepatocellular carcinoma cellsviathe mitochondrial pathwayWorld Journal of Gastroenterology, 2010
- Flavonoid consumption and esophageal cancer among black and white men in the United StatesInternational Journal of Cancer, 2009
- Natural compounds for cancer treatment and preventionPharmacological Research, 2009
- Drug resistance to 5-FU linked to reactive oxygen species modulator 1Biochemical and Biophysical Research Communications, 2007